BioSpace News Archive

Clionix will be the exclusive distributor of Strontium89 in Turkey, Saudi Arabia, Azerbaijan, Bulgaria, Romania, Egypt, Kuwait, & Pakistan

- Dr. Ruffner is a US-trained hematologist/oncologist with over 25 years of clinical care, oncology biotechnology and pharmaceutical drug development experience - Mr. Levine has over 20 years of corporate and investment banking experience in the biotechnology and pharmaceutical sectors - Inducement Grants Issued Pursuant to Nasdaq Listing Rule 5635(c)(4)

This week, Thermo Fisher Scientific will highlight its investments and innovations over the past 12 months across its global pharma services network, which have been focused on areas of accelerated demand including cell and gene therapy, drug product development, biologics manufacturing and clinical supply chain services.

Incisive Genetics Inc. announced the close of its $2.5 million seed financing. The financing syndicate was led by investors Noel Hall and Sandra MacPherson of the MacHall group and Haig Farris, OC.

Real-world study expands access to MDMA-assisted therapy for patients with PTSD and concurrent disorders and will provide data on a regulated model for MDMA-assisted therapy.

Caribou Biosciences, Inc. announced today that the first patient has been dosed in its open-label, multicenter ANTLER phase 1 clinical trial ( NCT04637763 ) to evaluate the company’s lead product candidate, CB-010.

PolarityTE, Inc. (Nasdaq: PTE) today announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese Patent Application No. 201580075326.3.

Regulatory News: Aptorum Group Limited announces further positive results of its ongoing Phase 1 clinical trial for ALS-4 (a first in-class anti-virulence approach based small molecule targeting.

Nemaura Medical, Inc. today announced that Chief Executive Officer Faz Chowdhury, Ph.D. will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021.

Petros Pharmaceuticals, Inc. today announced that President and Chief Commercial Officer Fady Boctor will present a corporate overview at the Access to Giving Virtual Investor Conference being held July 13 – 15, 2021.